Coronary artery disease detected by coronary computed tomographic angiography is associated with intensifcation of preventive medical therapy and lower low-density lipoprotein cholesterol

Circulation: Cardiovascular Imaging

Volumn 7, Issue 4, 2014, Pages 629-638

  Hulten, Edward ^a,b   Bittencourt, Marcio Sommer ^a,c   Singh, Avinainder ^a,d   O'Leary, Daniel ^a   Christman, Mitalee P ^a   Osmani, Wafa ^a   Abbara, Suhny ^h   Steigner, Michael L ^a   Truong, Quynh A ^d   Nasir, Khurram ^e   Rybicki, Frank F ^a   Klein, Josh ^a   Hainer, Jon ^a   Brady, Thomas J ^d   Hoffmann, Udo ^d   Ghoshhajra, Brian B ^d   Hachamovitch, Rory ^f,g   Di Carli, Marcelo F ^a   Blankstein, Ron ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d Cardiac MR PET CT Program   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f Center for Prevention and Wellness   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h NONE

Author keywords

Aspirin; Prevention and control; Prognosis

Indexed keywords

ASPIRIN; PREVENTION AND CONTROL; PROGNOSIS;

ASPIRIN; CHOLESTEROL, LDL; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84905827726     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.001564     Document Type: Article

References (32)

1. Scridon T, Novaro GM, Bush HS, Asher CR, Dandes E, Kabirdas D, Scridon C, Kuo BT, Whiteman M, Shen MY. Reclassifcation of patients for aggressive cholesterol treatment: additive value of multislice coronary angiography to the National Cholesterol Education Program guidelines. Clin Cardiol. 2008;31:419-423.
2. McEvoy JW, Blaha MJ, Nasir K, Yoon YE, Choi EK, Cho IS, Chun EJ, Choi SI, Rivera JJ, Blumenthal RS, Chang HJ. Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. Arch Intern Med. 2011;171:1260-1268.
3. Blankstein R, Murphy MK, Nasir K, Gazelle GS, Batlle JC, Al-Mallah M, Shturman L, Hoffmann U, Cury RC, Abbara S, Brady TJ, Lee TH. Perceived usefulness of cardiac computed tomography as assessed by referring physicians and its effect on patient management. Am J Cardiol. 2010;105:1246-1253.
4. LaBounty TM, Devereux RB, Lin FY, Weinsaft JW, Min JK. Impact of coronary computed tomographic angiography fndings on the medical treatment and control of coronary artery disease and its risk factors. Am J Cardiol. 2009;104:873-877.
5. Cheezum MK, Hulten EA, Smith RM, Taylor AJ, Kircher J, Surry L, York M, Villines TC. Changes in preventive medical therapies and CV risk factors after CT angiography. J Am Coll Cardiol Cardiovasc Imaging. 2013;6:574-581.
6. Ovrehus KA, Bøtker HE, Jensen JM, Munkholm H, Johnsen SP, Nørgaard BL. Infuence of coronary computed tomographic angiography on patient treatment and prognosis in patients with suspected stable angina pectoris. Am J Cardiol. 2011;107:1473-1479.
7. Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, Beanlands RS, Chow BJ, Branscomb E, Chareonthaitawee P, Weigold WG, Voros S, Abbara S, Yasuda T, Jacobs JE, Lesser J, Berman DS, Thomson LE, Raman S, Heller GV, Schussheim A, Brunken R, Williams KA, Farkas S, Delbeke D, Schoepf UJ, Reichek N, Rabinowitz S, Sigman SR, Patterson R, Corn CR, White R, Kazerooni E, Corbett J, Bokhari S, Machac J, Guarneri E, Borges-Neto S, Millstine JW, Caldwell J, Arrighi J, Hoffmann U, Budoff M, Lima J, Johnson JR, Johnson B, Gaber M, Williams JA, Foster C, Hainer J, Di Carli MF; SPARC Investigators. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol. 2012;59:462-474.
8. Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:897-907.
9. Kostis WJ, Moreyra AE, Cheng JQ, Dobrzynski JM, Kostis JB. Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy. J Clin Lipidol. 2011;5:97-104.
10. Pletcher MJ, Hulley SB. Statin therapy in young adults: ready for prime time? J Am Coll Cardiol. 2010;56:637-640.
11. Steinberg D. Earlier intervention in the management of hypercholesterol-emia: what are we waiting for? J Am Coll Cardiol. 2010;56:627-629.
12. Abbara S, Arbab-Zadeh A, Callister TQ, Desai MY, Mamuya W, Thomson L, Weigold WG. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2009;3:190-204.
13. Raff GL, Abidov A, Achenbach S, Berman DS, Boxt LM, Budoff MJ, Cheng V, DeFrance T, Hellinger JC, Karlsberg RP; Society of Cardiovascular Computed Tomography. SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr. 2009;3:122-136.
14. Bittencourt MS, Hulten E, Ghoshhajra B, O'Leary D, Christman MP, Montana P, Truong QA, Steigner M, Murthy VL, Rybicki FJ, Nasir K, Gowdak LH, Hainer J, Brady TJ, Di Carli MF, Hoffmann U, Abbara S, Blankstein R. Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. Circ Cardiovasc Imaging. 2014;7:282-291.
15. Lin FY, Shaw LJ, Dunning AM, Labounty TM, Choi JH, Weinsaft JW, Koduru S, Gomez MJ, Delago AJ, Callister TQ, Berman DS, Min JK. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2, 583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol. 2011;58:510-519.
16. Morise AP, Haddad WJ, Beckner D. Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease. Am J Med. 1997;102:350-356.
17. Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) fnal report. Circulation. 2002;106:3143-3421.
18. American Diabetic Association. Diagnosis and classifcation of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62-S69.
19. Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal defnition of myocardial infarction classifcation system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel- Thrombolysis in Myocardial Infarction 38). Circulation. 2012;125:577-583.
20. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
21. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
22. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantifcation of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827-832.
23. Davignon J. Benefcial cardiovascular pleiotropic effects of statins. Circulation. 2004;109(23 suppl 1):III39-III43.
24. McEvoy JW, Blaha MJ, Blumenthal RS. Rhinotillexis: a possible heuristic to reduce inappropriate noninvasive cardiac imaging? J Am Coll Cardiol. 2012;60:432; author reply 433.
25. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, Lippolis NJ, Berman DS, Callister TQ. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161-1170.
26. Hachamovitch R, Di Carli MF. Reply. J Am Coll Cardiol. 2012;60:433.
27. Nasir K, McClelland RL, Blumenthal RS, Goff DC Jr, Hoffmann U, Psaty BM, Greenland P, Kronmal RA, Budoff MJ. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: the Multi-Ethnic Study of Atherosclerosis (MESA). Circ Cardiovasc Qual Outcomes. 2010;3:228-235.
28. Rozanski A, Gransar H, Shaw LJ, Kim J, Miranda-Peats L, Wong ND, Rana JS, Orakzai R, Hayes SW, Friedman JD, Thomson LE, Polk D, Min J, Budoff MJ, Berman DS. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identifcation of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol. 2011;57:1622-1632.
29. Blankstein R, Dorbala S. Adding calcium scoring to myocardial perfusion imaging: Does it alter physicians' therapeutic decision making? J Nucl Cardiol. 2010;17:168-171.
30. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-1278.
31. Rouleau J. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. Am J Med. 2005;118 Suppl 12A:28-35.
32. Mills EJ, O'Regan C, Eyawo O, Wu P, Mills F, Berwanger O, Briel M. Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients. Eur Heart J. 2011;32:1409-1415.